May 25 | 18:11 IST
GST rates unlikely to impact medicine prices as life saving drugs get marked in in low tax basket
Medtech companies edifying healthcare beyond device use
Global med-tech firms, India locked in tussle after stent price sting
USFDA issues warning letter to Divis Labs for Vizag unit
Mahindra Partners forays into healthcare
Divis's Labs stock hits a 52-week low following USFDA import alert on key unit
Sun Pharma's Mohali plant gets a breather; all eyes now on Halol
Govt receives Rs 672-cr fine from pharma firms for overcharging
Dr Reddy's gets 13 observations after USFDA inspection of its oncology formulation plant
NPPA's 'suspicion' of drug overpricing upsets industry
Lupin gets USFDA nod to market cancer drug
Cipla bets on respiratory, oncology and HIV segments in Brazil and China
USFDA concludes inspection of Dr Reddy's Miryalaguda facility
India's NRA for medicines is lauded by WHO
Indian pharma asks US to exclude India from list of IPR offenders
Piramal Enterprises acquires Mallinckrodt's pharma products for $203 million
Clove Dental announces big plans to expand chain of dental clinics
Abbott to make India hub of global research and development for branded generics
Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm
Outlook for pharma, education and microfinance in 2017
Sun Pharma arm picks up 14.6 per cent stake in US company for $13 mn
Sun Pharma completes acquisition of Ocular Technologies Sarl
Indian pharma industry facing growth headwinds: ICRA
Cipla gets USFDA nod for Hepatitis B treatment drug
Demonetisation effect - medicine sales dip 10% in November
Relief for Vicks Action 500, Corex as HC quashes ban
Patients stocking daily-use medicines; deferring optional surgeries
Sanofi awaits govt approval to launch dengue vaccine in India
UN panel recommends policy tweaks for access to medicine
Apollo unveils Tomotherapy to boost precision cancer care